Invention Grant
US08828427B2 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
有权
4-氨基-2-（2,6-二氧代哌啶-3-基）异二氢吲哚-1,3-二酮的制剂
- Patent Title: Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
- Patent Title (中): 4-氨基-2-（2,6-二氧代哌啶-3-基）异二氢吲哚-1,3-二酮的制剂
-
Application No.: US12783390Application Date: 2010-05-19
-
Publication No.: US08828427B2Publication Date: 2014-09-09
- Inventor: Anthony Tutino , Michael T. Kelly
- Applicant: Anthony Tutino , Michael T. Kelly
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: A61K31/454
- IPC: A61K31/454 ; A61K9/48
Abstract:
Pharmaceutical compositions and single unit dosage forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease.
Public/Granted literature
- US20110045064A1 FORMULATIONS OF 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE Public/Granted day:2011-02-24
Information query
IPC分类:
